Safety Study of Nivolumab to Treat Advanced or Metastatic Non-small Cell Lung Cancer
Clinical trial NCT03090737 · COMPLETED
Trial details
- NCT number
- NCT03090737
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-02
- Primary completion
- 2021-02-16
- Enrollment
- 129
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.